The Program, coordinated through the University of Colorado Cancer Center, is currently based in 49 community clinics and partners with more than 250 screening, pathology, and treatment providers.
Through May 2012, the Program has completed more than 13,890 endoscopic screens and detected 118 cancers.
The Colorado Colorectal Screening Program has successfully competed for funding
for a three year grant, which will allow us to substantially restore activities
of the Program. The first year of the grant will span 9 months, beginning
The Program is cultivating a hybrid approach to screening with a primary focus on restoring endoscopic screens throughout Colorado, while also championing a comprehesive approach to screening by using high-sensitivity fecal occult blood tests (FOBT), both guaiac-based and fecal immunochemical.
The Program is providing support to clinics interested in FOBT to create an an organized approach for screening. A FOBT is a test that patients can do at home on a yearly basis. It screens for
colorectal cancer by detecting blood in the stool.
The Program is maintaining partnerships with providers and clinics to offer eligible patients endoscopic screens for screening, surveillance, and positive FOBT. For the 9 month grant, the Program aims to screen approximately 1850 Coloradans.
April 18, 2013
Our newly developed Flu-FOBT Toolkit is now available! This Program combines an annual stool test with existing Flu vaccine services. Start planning for Flu season now!
Our director, Holly Wolf, talks about March as Colorectal Cancer Awareness and our Program.
FOR IMMEDIATE RELEASE: MEDIA CONTACTS:
June 27, 2011 Bill Bradley, 916-213-5230
Denver Undy 5000 5K Draws Huge Crowd to
Bring Awareness to Colon Cancer
Denver, CO (June 27) – The Colon Cancer Alliance’s Denver Undy 5000 5K run was held on Saturday, June 25 at City Park for the third year in a row. Mayor Guillermo (Bill) Vidal was present to officially start the race, and Paul Weiss led a “moment of celebration” in memory of his wife, former Denver Councilwoman Carla Madison, who passed away from colon cancer earlier this year. Almost 1,300 people wearing underwear, boxer shorts or silly costumes participated in the event to help bring greater awareness to colon cancer, the 2nd leading cause of cancer death in the United States.
“Denver has done it again,” said Andrew Spiegel, CEO of the Colon Cancer Alliance. “The Undy 5000 was a great success. We had 74 survivors in attendance who were recognized for their valiant effort in beating this disease. And, to top it off, Denver supporters helped us raise more than $130,000!”
The Undy 5000 series, created by the Colon Cancer Alliance and held in cities across the nation, is designed to promote awareness and education about colon cancer. The event stresses the importance of timely colon cancer screening, and provides valuable information for those already affected by the disease. The American Cancer Society estimates that 142,000 new cases will be diagnosed this year and almost 50,000 people will succumb to the disease. Through recommended screenings, this cancer can be caught early when treatment is most effective — or even prevented altogether when pre-cancerous polyps are detected and removed.
The maker of Dulcolax®* is the proud presenting sponsor of the 2011 Undy 5000 races. As the #1 doctor-recommended stimulant for constipation relief, Dulcolax ® reminds everyone over the age of 50 or with a family history of colon cancer, that a colonoscopy can save lives.
Additional national sponsors include the American Society of Colon and Rectal Surgeons, Amgen, Genentech and Salix Pharmaceuticals. Local sponsors included Arapahoe Gastroenterology, Rocky Mountain Gastroenterology Associates, South Denver Gastroenterology, Diversified Radiology of Colorado, The Cancer Center Lutheran Medical Center, University of Colorado Cancer Center, Comprehensive Cancer Center, Saint Joseph Hospital, Ah-Some Photography, and Tony’s Market.
# # #
The Colon Cancer Alliance (CCA) is a national patient advocacy organization dedicated to ending the suffering caused by colorectal cancer. In order to increase rates of screening and survivorship, the CCA provides patient support, public education, supports research and conducts advocacy work across America.